BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Biotech Bay

  Exelixis Announces Webcasts of Investor Conference Presentations in March 2020

  Exelixis, Inc. announced that members of Exelixis’ management team will provide a corporate overview at the following investor conferences in March

  February 26, 2020

   · 

  2 min read
• Drug Development

  Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology

  Data showed improvement in both heartburn and regurgitation symptoms and further demonstrated the role of bile acid in refractory gastroesophageal reflux disease (GERD)

  February 26, 2020

   · 

  9 min read
• Biotech Beach

  Active Motif clones, sequences and expresses the first full human antibody derived from patients infected with the 2019 Coronavirus COVID-19

  Active Motif Shanghai, in collaboration with Fudan University and its affiliated Public Health Clinical Center, used its single-cell AbEpic™ screening technology to isolate antibodies from patients recovering from 2019 Coronavirus related pneumonia.

  February 26, 2020

   · 

  1 min read
• Deals

  Cigna Declares Annual Dividend payable on April 9, 2020

  The board of directors of Cigna Corporation declared a cash dividend of $0.04 per share of Cigna common stock, payable on April 9, 2020 to shareholders of record as of the close of business on March 10, 2020.

  February 26, 2020

   · 

  1 min read
• Business

  Natera Reports Fourth Quarter and Year 2019 Financial Results

  Natera, Inc., a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, reported financial results for the fourth quarter and the year ended December 31, 2019 and provided an update on recent business progress.

  February 26, 2020

   · 

  12 min read
• Business

  Viking Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update

  Viking Therapeutics, Inc. announced its financial results for the fourth quarter and year ended December 31, 2019, and provided an update on its clinical pipeline and other corporate developments.

  February 26, 2020

   · 

  12 min read
• Business

  Universal Health Services, Inc. Reports 2019 Fourth Quarter And Full Year Financial Results And 2020 Full Year Earnings Guidance

  Consolidated Results of Operations, As Reported and As Adjusted -- Three-month periods ended December 31, 2019 and 2018

  February 26, 2020

   · 

  21 min read
• Deals

  IMD Joins West Side United Collaborative Pledging Financial Investments to Improve Health Outcomes on Chicago’s West Side

  Multi-year commitment aims to help offset drivers of health disparities such as access to care, education, economic opportunity and the physical environment

  February 26, 2020

   · 

  4 min read
• BioMidwest

  Treatment for blindness successful in largest ever study

  A new treatment has been found to be successful in improving the vision of partially blind patients.

  February 26, 2020

   · 

  3 min read
• Policy

  Information Update - Certain Metformin diabetes drugs recalled due to the presence of NDMA

  Products contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), above or close to the acceptable limit.

  February 26, 2020

   · 

  5 min read